The Cancer Research and Prevention Institute of Texas (CPRIT) today announced funding in excess of $81 million to support cancer research and commercialization projects in Texas. The 25 newly funded projects bring the total amount of grants by CPRIT since its inception in 2007 to more than $650 million.
This latest round of funding includes $20 million for a Houston-area pre-commercialization center to “incubate” promising oncology-focused technologies, as well as three CPRIT Scholar in Cancer Research awards to attract top investigators in oncology research to Texas. In addition, Cell Medica, a leading company that develops cellular immunotherapies for oncologic applications, will relocate its headquarters from the UK to Texas, bringing with it jobs and plans to establish a manufacturing and distribution facility in the state.
To read the full, original article click on this link: State Institute Awards More Than $81 Million to Support Cancer Drug Discovery and Development in Texas - MarketWatch
